Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1

Kidney International

Volumn 75, Issue 2, 2009, Pages 185-196

  Raffetseder, Ute ^a   Rauen, Thomas ^a   Djudjaj, Sonja ^a   Kretzler, Matthias ^b   En Nia, Abdelaziz ^a   Tacke, Frank ^a   Zimmermann, Henning W ^a   Nelson, Peter J ^c   Frye, Björn C ^a   Floege, Jürgen ^a   Stefanidis, Ioannis ^d   Weber, Christian ^a   Mertens, Peter R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

Acute rejection; Chemokines; Cold shock proteins; Monocytes; Renal transplantation; Y box protein 1

Indexed keywords

RANTES; Y BOX BINDING PROTEIN 1;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CELL; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; T LYMPHOCYTE; UPREGULATION;

BIOPSY; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL5; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; INFLAMMATION; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MONOCYTES; T-LYMPHOCYTES; Y-BOX-BINDING PROTEIN 1;

EID: 58149151372     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.457     Document Type: Article

References (55)

1. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988-1996. N Engl J Med 2000; 342: 605-612.
2. Humar A, Payne WD, Sutherland DE et al. Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplantation 2000; 69: 2357-2360.
3. Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 1930-1941.
4. Erren M, Arlt M, Willeke P et al. Predictive value of the CD45RO positive T-helper lymphocyte subset for acute cellular rejection during the early phase after kidney transplantation. Transplant Proc 1999; 31: 319-321.
5. Grimm PC, McKenna R, Nickerson P et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999; 10: 1582-1589.
6. Hancock WW. Chemokines and transplant immunobiology. J Am Soc Nephrol 2002; 13: 821-824.
7. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74: 149-155.
8. Gao W, Faia KL, Csizmadia V et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001; 72: 1199-1205.
9. Hancock WW, Gao W, Csizmadia V et al. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001; 193: 975-980.
10. Koga S, Auerbach MB, Engeman TM et al. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. J Immunol 1999; 163: 4878-4885.
11. Horuk R, Shurey S, Ng HP et al. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett 2001; 76: 193-201.
12. Panzer U, Reinking RR, Steinmetz OM et al. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 2004; 78: 1341-1350.
13. Grone HJ, Weber C, Weber KS et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999; 13: 1371-1383.
14. Song E, Zou H, Yao Y et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002; 61: 676-685.
15. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176.
16. Wilson HM, Walbaum D, Rees AJ. Macrophages and the kidney. Curr Opin Nephrol Hypertens 2004; 13: 285-290.
17. Shi C, Simon DI. Integrin signals, transcription factors, and monocyte differentiation. Trends Cardiovasc Med 2006; 16: 146-152.
18. Shi C, Zhang X, Chen Z et al. Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest 2004; 114: 408-418.
19. Mertens PR, Alfonso-Jaume MA, Steinmann K et al. YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. J Am Soc Nephrol 1999; 10: 2480-2487.
20. En-Nia A, Yilmaz E, Klinge U et al. Transcription factor YB-1 mediates DNA polymerase alpha gene expression. J Biol Chem 2005; 280: 7702-7711.
21. Raffetseder U, Frye B, Rauen T et al. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem 2003; 278: 18241-18248.
22. Chen CY, Gherzi R, Andersen JS et al. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000; 14: 1236-1248.
23. Mertens PR, Harendza S, Pollock AS et al. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 1997; 272: 22905-22912.
24. Krohn R, Raffetseder U, Bot I et al. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 2007; 116: 1812-1820.
25. Diamond P, Shannon MF, Vadas MA et al. Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cells. J Biol Chem 2001; 276: 7943-7951.
26. Tsuchiya S, Kobayashi Y, Goto Y et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42: 1530-1536.
27. MacDonald GH, Itoh-Lindstrom Y, Ting JP. The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter. J Biol Chem 1995; 270: 3527-3533.
28. Pattison J, Nelson PJ, Huie P et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 343: 209-211.
29. Schlondorff D, Nelson PJ, Luckow B et al. Chemokines and renal disease. Kidney Int 1997; 51: 610-621.
30. Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001; 14: 377-386.
31. Nelson PJ, Kim HT, Manning WC et al. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993; 151: 2601-2612.
32. Ortiz BD, Nelson PJ, Krensky AM. Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today 1997; 18: 468-471.
33. van Roeyen CR, Eitner F, Martinkus S et al. Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 2005; 16: 2985-2996.
34. Capowski EE, Esnault S, Bhattacharya S et al. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunol 2001; 167: 5970-5976.
35. Stenina OI, Poptic EJ, DiCorleto PE. Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J Clin Invest 2000; 106: 579-587.
36. Basaki Y, Hosoi F, Oda Y et al. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 2007; 26: 2736-2746.
37. Bargou RC, Jurchott K, Wagener C et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 1997; 3: 447-450.
38. Shibahara K, Sugio K, Osaki T et al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer. Clin Cancer Res 2001; 7: 3151-3155.
39. Sutherland BW, Kucab J, Wu J et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005; 24: 4281-4292.
40. Didier DK, Schiffenbauer J, Woulfe SL et al. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 1988; 85: 7322-7326.
41. Ting JP, Painter A, Zeleznik-Le NJ et al. YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes. J Exp Med 1994; 179: 1605-1611.
42. Nikolcheva T, Pyronnet S, Chou SY et al. A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest 2002; 110: 119-126.
43. Martin M, Schwinzer R, Schellekens H et al. Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. J Immunol 1989; 142: 1887-1894.
44. Baud L, Hagege J, Sraer J et al. Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity. J Exp Med 1983; 158: 1836-1852.
45. Norman JT, Lindahl GE, Shakib K et al. The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 2001; 276: 29880-29890.
46. Mayer V, Hudkins KL, Heller F et al. Expression of the chemokine receptor CCR1 in human renal allografts. Nephrol Dial Transplant 2007; 22: 1720-1729.
47. Valledor AF, Borras FE, Cullell-Young M et al. Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol 1998; 63: 405-417.
48. Tsai FY, Keller G, Kuo FC et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371: 221-226.
49. Lerga A, Crespo P, Berciano M et al. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation. Cell Growth Differ 1999; 10: 639-654.
50. Barrett JF, Lewis BC, Hoang AT et al. Cyclin A links c-Myc to adhesionin-dependent cell proliferation. J Biol Chem 1995; 270: 15923-15925.
51. Jurchott K, Bergmann S, Stein U et al. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 2003; 278: 27988-27996.
52. Mertens PR, Alfonso-Jaume MA, Steinmann K et al. A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 1998; 273: 32957-32965.
53. Schmid H, Cohen CD, Henger A et al. Gene expression analysis in renal biopsies. Nephrol Dial Transplant 2004; 19: 1347-1351.
54. Boehlk S, Fessele S, Mojaat A et al. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells. Eur J Immunol 2000; 30: 1102-1112.
55. Dooley S, Said HM, Gressner AM et al. Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 2006; 281: 1784-1795.